PARP inhibitor study

Research update

FacingOurRisk.orgA study on PARP inhibitors for advanced breast cancer is now open at many sites across the US and Internationally! You can help if you:

  • Have a BRCA1 or BRCA2 mutation
  • Have confirmed metastatic breast cancer
  • Her2neu negative (or Her2neu positive and have received previous anti-Her2neu therapy or are ineligible for anti-Her2neu therapy)
  • Have measurable disease

Learn more about the study, on the FORCE website.

Free webinar

FORCE will also host a free webinar: Updates on PARP Inhibitor Research.

Date: Thursday, February 28, 2013
Time: 12pm -1pm ET
Speaker: Susan Domchek, MD, Executive Director of the Basser Research Center for BRCA
More info

While you’re at it

Help FORCE and Celebration Health by participating in a survey about long-term follow-up healthcare for preivors and survivors. This will provide important info about long-term health concerns for women with BRCA and other hereditary cancer syndromes.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s